Analysis and Commentary 9/28/18 Analysis and Commentary 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More Advocacy at a Glance 9/28/18 Advocacy at a Glance 9/28/18 Advocacy at a Glance Read More Analysis and Commentary 9/21/18 Analysis and Commentary 9/21/18 Positive Thoughts on an Imperiled Four-Bill Minibus Read More Advocacy at a Glance 9/21/18 Advocacy at a Glance 9/21/18 Advocacy at a Glance Read More Analysis and Commentary 9/14/18 Analysis and Commentary 9/14/18 Three Possible Ways to Hatch an Egg Read More Advocacy at a Glance 9/14/18 Advocacy at a Glance 9/14/18 Advocacy at a Glance Read More 9/7/18 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More Advocacy at a Glance 9/7/18 Advocacy at a Glance 9/7/18 Advocacy at a Glance Read More Analysis and Commentary 8/31/18 Analysis and Commentary 8/31/18 On the Physical Capabilities of a Lame Duck Read More Advocacy at a Glance 8/31/18 Advocacy at a Glance 8/31/18 Advocacy at a Glance Read More Analysis and Commentary 8/24/18 Analysis and Commentary 8/24/18 August as Usual in DC? Definitively NOT! Read More Advocacy at a Glance 8/24/18 Advocacy at a Glance 8/24/18 Advocacy at a Glance Read More Advocacy at a Glance 8/17/18 Advocacy at a Glance 8/17/18 Sometimes There Really Is a Win-Win Read More Advocacy at a Glance 8/17/18 Advocacy at a Glance 8/17/18 Advocacy at a Glance Read More Analysis and Commentary 8/5/18 Analysis and Commentary 8/5/18 The Full Senate Position on FDA's FY 19 Appropriation Read More Advocacy at a Glance 8/5/18 Advocacy at a Glance 8/5/18 Advocacy at a Glance Read More Advocacy at a Glance 7/27/18 Advocacy at a Glance 7/27/18 FDA's Appropriation for FY 19: Upsides and Downsides Read More Advocacy at a Glance 7/27/18 Advocacy at a Glance 7/27/18 Advocacy at a Glance Read More 7/24/18 7/24/18 “First, do no harm” Read More Advocacy at a Glance 7/24/18 Advocacy at a Glance 7/24/18 Advocacy at a Glance Read More Newer Posts Older Posts
Analysis and Commentary 9/28/18 Analysis and Commentary 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More
Analysis and Commentary 9/21/18 Analysis and Commentary 9/21/18 Positive Thoughts on an Imperiled Four-Bill Minibus Read More
Analysis and Commentary 9/14/18 Analysis and Commentary 9/14/18 Three Possible Ways to Hatch an Egg Read More
Analysis and Commentary 8/31/18 Analysis and Commentary 8/31/18 On the Physical Capabilities of a Lame Duck Read More
Analysis and Commentary 8/24/18 Analysis and Commentary 8/24/18 August as Usual in DC? Definitively NOT! Read More
Advocacy at a Glance 8/17/18 Advocacy at a Glance 8/17/18 Sometimes There Really Is a Win-Win Read More
Analysis and Commentary 8/5/18 Analysis and Commentary 8/5/18 The Full Senate Position on FDA's FY 19 Appropriation Read More
Advocacy at a Glance 7/27/18 Advocacy at a Glance 7/27/18 FDA's Appropriation for FY 19: Upsides and Downsides Read More
